Research Topics
Species | C H AdlerSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Disassembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patientsZhenyu Zhong
Haldeman Laboratory of Molecular and Cellular Neurobiology, Sun Health Research Institute, Sun City, AZ USA
Mol Neurodegener 4:30. 2009..ABSTRACT: Correction to Nural H, He P, Beach T, Sue L, Xia W, Shen Y. Disassembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patients Molecular Neurodegeneration 2009, 4:23...
Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)Joseph Jankovic
Baylor College of Medicine, Department of Neurology, Houston, TX, USA
BMC Neurol 11:140. 2011..Irvine, CA, USA). Methods and baseline demographics from an interim analysis are provided...
Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's diseaseCharles H Adler
Parkinson s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic Scottsdale, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA
Mov Disord 18:287-93. 2003..Our data demonstrate that, in a small sample size, administration of 200 mg/day of modafinil was associated with few side effects and was modestly effective for the treatment of excessive daytime sleepiness in patients with PD...
Incidental Lewy body disease: clinical comparison to a control cohortCharles H Adler
Parkinson s Disease and Movement Disorders Center, Mayo Clinic, Scottsdale, Arizona 85259, USA
Mov Disord 25:642-6. 2010..Larger sample size is needed to have the power to better assess group differences...
Abnormal co-contraction in yips-affected but not unaffected golfers: evidence for focal dystoniaC H Adler
Parkinson's Disease and Movement Disorders Center, Mayo Clinic Scottsdale, Scottsdale, AZ 85259, USA
Neurology 64:1813-4. 2005
Perioperative use of botulinum toxinsCharles H Adler
Parkinson s Disease and Movement Disorders Center, Mayo Clinic, Department of Neurology, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA
Toxicon 54:654-7. 2009..Botulinum toxins are not commonly thought of as adjuncts to surgical procedures. This article reviews some of the perioperative uses of botulinum toxins...
Ropinirole for restless legs syndrome: a placebo-controlled crossover trialC H Adler
Parkinson s Disease and Movement Disorders Center, Mayo Clinic Scottsdale, AZ 85259, USA
Neurology 62:1405-7. 2004..Eight of the 22 patients had complete resolution of symptoms on ropinirole. Adverse events included nausea and dizziness. Ropinirole was effective and well tolerated for treating the symptoms of RLS...
Botulinum toxin type A for treating voice tremorCharles H Adler
Parkinson s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic Scottsdale, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA
Arch Neurol 61:1416-20. 2004..Voice tremor, like spasmodic dysphonia and other tremor disorders, may respond to botulinum toxin type A injections...
Sleep issues in Parkinson's diseaseCharles H Adler
Parkinson s Disease and Movement Disorders Center, Mayo Clinic Scottsdale, 13400 East Shea Boulevard, Scottsdale, AZ 85256, USA
Neurology 64:S12-20. 2005..Effective management of sleep disturbances and excessive daytime sleepiness can greatly improve the quality of life for patients with PD...
Nonmotor complications in Parkinson's diseaseCharles H Adler
Parkinson s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA
Mov Disord 20:S23-9. 2005..This review will discuss many of the nonmotor complications in PD, including cognitive, autonomic, sleep, and sensory difficulties that may occur...
Motor impairment in normal aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: longitudinal evaluation of a cohort of prospective brain donorsCharles H Adler
Parkinson s Disease and Movement Disorders Center, Mayo Clinic Scottsdale, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA
Parkinsonism Relat Disord 9:103-10. 2002..This study underscores the importance of longitudinal antemortem testing of prospective brain donors as well as the potential value of quantitative motor testing...
Essential tremor and Parkinson's disease: lack of a linkCharles H Adler
Parkinson s Disease and Movement Disorders Center, Mayo Clinic, Scottsdale, Arizona 85259, USA
Mov Disord 26:372-7. 2011..Essential tremor (ET) is a very common disorder and proving that there is a relationship to another common movement disorder, Parkinson's disease (PD), has been debated for years...
Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndromeCharles H Adler
Department of Neurology, Mayo Clinic, Scottsdale, AZ 85259, USA
Parkinsonism Relat Disord 17:456-8. 2011..Compare the frequency of REM sleep behavior disorder (RBD) and excessive daytime sleepiness (EDS) in Parkinson's disease (PD), restless legs syndrome (RLS), essential tremor (ET), and control subjects...
Strategies for controlling dystonia. Overview of therapies that may alleviate symptomsC H Adler
Department of Neurology, Mayo Clinic Scottsdale, AZ 85259, USA
Postgrad Med 108:151-2, 155-6, 159-60. 2000..Surgical treatment of dystonia may be performed peripherally or centrally but is usually reserved for patients in whom other forms of therapy fail...
Are the yips a task-specific dystonia or "golfer's cramp"?Charles H Adler
Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA
Mov Disord 26:1993-6. 2011..2%). Golfers with video evidence of an involuntary movement while putting have excessive rotation of the right wrist in a pronation/supination motion and, as previously reported, a trend for wrist flexor/extensor cocontraction...
Relevance of motor complications in Parkinson's diseaseCharles H Adler
Parkinson s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, AZ 85259, USA
Neurology 58:S51-6. 2002..Overall, quality of life suffers. In addition, there is a marked increase in the expense to both the patient and society when motor fluctuations and dyskinesias develop...
Premotor symptoms and early diagnosis of Parkinson's diseaseCharles H Adler
Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, USA
Int J Neurosci 121:3-8. 2011..What is becoming increasingly clear is that nonmotor findings, including hyposmia, sleep disorders, autonomic abnormalities, cognitive changes, and neurobehavioral changes, often precede the motor findings...
Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystoniaCharles H Adler
Parkinson s Disease and Movement Disorders Center, Mayo Clinic Scottsdale, Scottsdale, Arizona, USA
Mov Disord 17:158-61. 2002..We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6-year period...
Quantitative EEG as a predictive biomarker for Parkinson disease dementiaB T Klassen
Department of Neurology, Mayo Clinic, Scottsdale, AZ 85259, USA
Neurology 77:118-24. 2011..A reliable predictive QEEG biomarker for PD dementia (PD-D) incidence would be valuable for studying PD-D, including treatment trials aimed at preventing cognitive decline in PD...
A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremorM F Brin
Department of Neurology, Columbia University, New York, NY, USA
Neurology 56:1523-8. 2001..Hand weakness is a dose-dependent significant side effect of treatment at the doses used in this study...
Electrophysiology of the myoclonus in dementia with Lewy bodiesJ N Caviness
Department of Neurology, Mayo Clinic Scottsdale, AZ 85259, USA
Neurology 60:523-4. 2003
Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's diseaseV G H Evidente
Department of Neurology Department of Neurological Surgery, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA
Acta Neurol Scand 124:211-4. 2011..To compare the medication dose reduction between deep brain stimulation (DBS) of the globus pallidus interna (GPi) vs subthalamic nucleus (STN) in matched patients with Parkinson's disease (PD)...
Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's diseaseJ N Caviness
Department of Neurology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ, USA
Parkinsonism Relat Disord 13:348-54. 2007..PD-MCI has mean quantitative EEG characteristics that represent an intermediate electrophysiological state between PD-CogNL and PD-D...
Case studies in movement disordersVirgilio Gerald H Evidente
Movement Disorders Division, Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, USA
Semin Neurol 23:277-84. 2003..A detailed discussion of botulinum toxin follows the case on cervical dystonia, focusing on its mechanism of action, clinical indications, side effects, and dosing...
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystoniaJ Jankovic
Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, TX 77030, USA
Neurology 67:2233-5. 2006..One-third of the patients who were negative for BTX-B Abs at baseline became positive for BTX-B Abs at last visit. Thus, the high antigenicity of BTX-B limits its long-term efficacy...
Motor unit number estimates in idiopathic Parkinson's diseaseJ N Caviness
Department of Neurology, Mayo Clinic Scottsdale, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA
Parkinsonism Relat Disord 8:161-4. 2002..Progress in decreasing the variance of MUNEs will facilitate their use in detecting small motor unit number changes in neurodegenerative disease...
The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptomsCharlene Hoffman Snyder
Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona 85259, USA
J Am Acad Nurse Pract 19:179-97. 2007..The discussion provides treatment strategies that may offer improved ability to manage the disabling symptoms of this neurodegenerative disorder...
The 'yips' in golf: a continuum between a focal dystonia and chokingAynsley M Smith
Sports Medicine Center, Mayo Clinic, Rochester, Minnesota 55905, USA
Sports Med 33:13-31. 2003..A theoretical model provides a guide for future research on golfers with either type I or type II 'yips'...
Gambling and increased sexual desire with dopaminergic medications in restless legs syndromeErika D Driver-Dunckley
Department of Neurology, Parkinson s Disease and Movement Disorders Center, Mayo Clinic, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA
Clin Neuropharmacol 30:249-55. 2007..Do patients with restless legs syndrome (RLS) report gambling or other abnormal behaviors as previously reported in Parkinson disease...
An update on the neurologic applications of botulinum toxinsVirgilio Gerald H Evidente
Department of Neurology, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA
Curr Neurol Neurosci Rep 10:338-44. 2010..This article highlights some of the common neurologic conditions currently improved by botulinum toxins and reviews the scientific evidence from research studies and clinical experience with these conditions...
Parkinson's disease dementia and potential therapeutic strategiesJohn N Caviness
Mayo Clinic College of Medicine, Mayo Clinic, USA
CNS Neurosci Ther 17:32-44. 2011..More research is needed on the specific aspects of cortical dysfunction and degeneration that create PD-D...
Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementiaAmy C Almaraz
Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, USA
Neurologist 15:234-7. 2009..Therefore, cholinesterase inhibitors might improve cognitive function in PDD. On the other hand, enhancing cholinergic function could plausibly worsen features of parkinsonism...
Defining mild cognitive impairment in Parkinson's diseaseJohn N Caviness
Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA
Mov Disord 22:1272-7. 2007..Defining PD-MCI offers an opportunity for further study of cognitive impairment in PD and targets for earlier therapeutic intervention...
Abnormal corticomuscular coherence is associated with the small amplitude cortical myoclonus in Parkinson's diseaseJohn N Caviness
Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, Arizona 85259, USA
Mov Disord 18:1157-62. 2003..These results have mechanistic implications for cortical dysfunction in Parkinson's disease and for cortical myoclonus in general...
Small-amplitude cortical myoclonus in Parkinson's disease: physiology and clinical observationsJohn N Caviness
Parkinson s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, Arizona 85259, USA
Mov Disord 17:657-62. 2002..Although the myoclonus occurred without dementia in these cases, its relationship to the subsequent development of cognitive impairment remains to be defined...
Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinomaSteven Vernino
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Ann Neurol 51:625-30. 2002..Four patients improved with chemotherapy, and 2 improved with intravenous methylprednisolone...
Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphoniaCharles H Adler
Parkinson s Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic Scottsdale, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
Mov Disord 19:1075-9. 2004..Breathiness was the most common side effect but was mild in intensity and of short duration. We conclude that BoNT-B is safe and effective for the treatment of adductor spasmodic dysphonia...
Myoclonus in Lewy body disordersJohn N Caviness
Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, Arizona, USA
Adv Neurol 89:23-30. 2002
Corticomuscular coherence is increased in the small postural tremor of Parkinson's diseaseJohn N Caviness
Department of Neurology, Mayo Clinic, Scottsdale, AZ 85259, USA
Mov Disord 21:492-9. 2006..The small amplitude postural tremor in PD arises from heterogeneous oscillator mechanisms. The discovery of increased corticomuscular coupling shows cortical involvement in the small amplitude postural tremor of PD...
Serum leptin concentrations and satiety in Parkinson's disease patients with and without weight lossV G Evidente
Mayo Clinic Scottsdale, Scottsdale, Arizona 85259, USA
Mov Disord 16:924-7. 2001..The results indicate that unintended weight loss in PD patients is unlikely to be due to abnormal serum leptin concentrations...
Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders?Jonathan H McKinnon
Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA
Neurologist 13:382-5. 2007..A recent American Academy of Neurology practice parameter indicated that olfactory testing was "probably useful" for differentiating idiopathic Parkinson disease (IPD) from other diseases with features of parkinsonism...
Headache and facial pain responsive to botulinum toxin: an unusual presentation of blepharospasmS J Johnstone
Department of Neurology, Barrow Neurologic Institute, Phoenix, AZ 85013, USA
Headache 38:366-8. 1998..This patient illustrates the importance of looking for blepharospasm in patients who present with headache or face pain, as her pain and blepharospasm were successfully treated with botulinum toxin type A injections...
Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulationErika Driver-Dunckley
Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, Arizona, USA
Mov Disord 21:1287-9. 2006..Despite a mean 56% decrease in their levodopa equivalents postoperatively, their RLS scores dropped by a mean of 84% (100% in three). Our findings suggest that bilateral STN DBS surgery can improve RLS in patients with advanced PD...
Altered aiming movements in Parkinson's disease patients and elderly adults as a function of delays in movement onsetDiana H Romero
Motor Control Laboratory, Arizona State University, Arizona, USA
Exp Brain Res 151:249-61. 2003..It can be inferred from the results that the decay in position sense as a function of time produces impairments in incorporating the initial limb position in motor planning process...
Characterization of DCTN1 genetic variability in neurodegenerationC Vilariño-Güell
Molecular Genetics Laboratory and Core, Morris K Udall Parkinson s Disease Research Center of Excellence, Mayo Clinic, Department of Neuroscience, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Neurology 72:2024-8. 2009....
Case series of painful legs and moving toes: clinical and electrophysiologic observationsMaria V Alvarez
Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, USA
Mov Disord 23:2062-6. 2008..Movements were partially suppressible and were diminished but still apparent during light sleep. GABAergic agents were most effective in controlling the pain and the movements...
Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trialArthur S Walters
Department of Neurology, Vanderbilt University Medical Center, 1161 21st Ave, Nashville, TN 37232 2551, USA
Clin Neuropharmacol 32:311-20. 2009..Assess the efficacy and tolerability of gabapentin enacarbil (GEn), a transported prodrug of gabapentin with improved gabapentin exposure, in adults with moderate-to-severe primary restless legs syndrome...
Genomic investigation of alpha-synuclein multiplication and parkinsonismOwen A Ross
Division of Neurogenetics, Department of Neuroscience, College of Medicine, Mayo Clinic, Jacksonville, FL 32224, USA
Ann Neurol 63:743-50. 2008..Herein we characterize five families with parkinsonism that have been identified to harbor multiplication of the chromosomal 4q21 locus containing the alpha-synuclein gene (SNCA)...
Parkinsonism, FXTAS, and FMR1 premutationsMathias Toft
Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA
Mov Disord 20:230-3. 2005..Five patients (1.2%) carry intermediate-size alleles (41-54 CGG repeats). Expansions within the FMR1 gene are not associated with PD in our study...
GCH1 in early-onset Parkinson's diseaseStephanie A Cobb
Division of Neurogenetics, Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA
Mov Disord 24:2070-5. 2009..This study does not support a significant role for genetic variation at the GCH1 locus in EOPD. However, our results further highlight the relevance of PRKN screening in familial EOPD...
Parkinson's disease and sleepMichael J Thorpy
Sleep Wake Disorders Center, Montefiore Medical Center, Bronx, NY 10467 2490, USA
Neurol Clin 23:1187-208. 2005..Treatment of sleepiness involves treating any underlying sleep disturbance and may involve the use of stimulant or alerting medications in the daytime...
Research priorities in spasmodic dysphoniaChristy L Ludlow
Laryngeal and Speech Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
Otolaryngol Head Neck Surg 139:495-505. 2008..To identify research priorities to increase understanding of the pathogenesis, diagnosis, and improved treatment of spasmodic dysphonia...
Reduced striatal tyrosine hydroxylase in incidental Lewy body diseaseThomas Gerald Beach
Sun Health Research Institute, 10515 West Santa Fe Drive, Sun City, AZ 85351, USA
Acta Neuropathol 115:445-51. 2008..8% (P = 0.01) reduction in ILBD cases, as compared with control cases. The finding suggests that ILBD is not a benign condition but is likely a precursor to PD and/or DLB...
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventionsChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 23:690-9. 2008..Recognition of factors that impact placebo response rates should be incorporated into individual study designs for PD clinical trials...
Botulinum toxin type B (Myobloc) in subjects with hemifacial spasm: results from an open-label, dose-escalation safety studyRichard M Trosch
The Parkinson s Disease and Movement Disorders Center, 26400 W, Southfield, Michigan, USA
Mov Disord 22:1258-64. 2007..Evaluate the safety of botulinum toxin type B (BoNT-B) in subjects with hemifacial spasm (HFS)...
Adaptation to changes in vertical display gain during handwriting in Parkinson's disease patients, elderly and young controlsJose L Contreras-Vidal
Department of Kinesiology and Neuroscience and Cognitive Science Program, University of Maryland, 2363 HHP Building, College Park 20742 2611, USA
Parkinsonism Relat Disord 9:77-84. 2002..These results may have implications for the treatment of micrographia in Parkinsonism...
Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's diseaseMathias Toft
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida 32224, USA
Mov Disord 22:389-92. 2007..3; 95% CI: 0.6-2.8; P = 0.45). These findings highlight the importance of using family-based studies and multiple population screenings when examining the association of these polymorphic LRRK2 gene variants with Parkinson's disease...
Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathologySean J Pittock
Department of Neurology Mayo Clinic, Rochester, Minnesota 55905, USA
Mov Disord 19:695-9. 2004..The absence of diagnostic microscopic brain or spinal cord pathology suggests that the pathologic substrate may be neurochemical or receptor based...
Genetics of restless legs syndromeIgnacio F Mata
Department of Neuroscience, Mayo Clinic College of Medicine, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 12:1-7. 2006..Herein, we review the current status of genetics in RLS, providing some methodological guidelines to help future research...
Time delays prior to movement alter the drawing kinematics of elderly adultsDiana H Romero
Motor Control Laboratory, Arizona State University, PEBE Room 107B, Tempe 85287 0404, USA
Hum Mov Sci 22:207-20. 2003..The findings provide evidence that decays in position sense as a function of time create difficulties in incorporating the initial limb position in motor planning process in elderly adults...
Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment depositsThomas G Beach
Sun Health Research Institute, 10515 West Santa Fe Drive, Sun City, AZ 85351, USA
Acta Neuropathol 114:419-24. 2007....
